Back to top
more

GEN DIGITAL INC (GEN)

(Delayed Data from NSDQ)

$30.45 USD

30.45
10,080,020

+2.18 (7.71%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $30.44 -0.01 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 244)

Industry: Technology Services

Zacks News

Zacks Equity Research

The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare

The Zacks Analyst Blog Highlights: MDU Resources, AquaVenture, Tenet Healthcare, US Foods and Genesis Healthcare

Zacks Equity Research

5 Safe Stocks to Counter IMF's Dull Global Economic Outlook

Global economy is slowing down and IMF has turned pessimistic. This is the perfect time for investors to go defensive and invest in these five stocks.

Zacks Equity Research

Genesis Healthcare (GEN) Flat As Market Sinks: What You Should Know

Genesis Healthcare (GEN) closed the most recent trading day at $1.52, making no change from the previous trading session.

Zacks Equity Research

The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet

The Zacks Analyst Blog Highlights: NRG Energy, Lannett Company, Genesis Healthcare, US Foods and Grocery Outlet

Zacks Equity Research

Buy These 5 Defensive Stocks to Counter Market Volatility

Markets have turned volatile due to poor economic data and geopolitical tensions, here are five defensive stocks to boost your portfolio.

Sapna Bagaria headshot

Nursing Industry Outlook Buoyant on Increasing Life Expectancy

Aging baby boomer population, need for low-cost care facilities and consolidation should aid the growth of the nursing industry.

Zacks Equity Research

Is Genesis Healthcare (GEN) Stock Outpacing Its Medical Peers This Year?

Is (GEN) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Genesis Healthcare (GEN) Flat As Market Gains: What You Should Know

In the latest trading session, Genesis Healthcare (GEN) closed at $1.17, marking no change from the previous day.

Zacks Equity Research

Genesis Healthcare Sees Hammer Chart Pattern: Time to Buy?

Genesis Healthcare has been struggling lately, but the selling pressure may be coming to an end soon.

Zacks Equity Research

Genesis Healthcare (GEN) Gains But Lags Market: What You Should Know

Genesis Healthcare (GEN) closed the most recent trading day at $1.19, moving +0.42% from the previous trading session.

Zacks Equity Research

How Genesis Healthcare (GEN) Stock Stands Out in a Strong Industry

Genesis Healthcare (GEN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Equity Research

Has Genesis Healthcare (GEN) Outpaced Other Medical Stocks This Year?

Is (GEN) Outperforming Other Medical Stocks This Year?

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 25th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 23rd

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

Zacks Equity Research

Genesis Healthcare, Inc. (GEN) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Genesis Healthcare, Inc. (GEN).

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 16th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday

Zacks Equity Research

Is Genesis Healthcare (GEN) Outperforming Other Medical Stocks This Year?

Is (GEN) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Top Ranked Momentum Stocks to Buy for September 5th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 5th

Tirthankar Chakraborty headshot

New Strong Buy Stocks for September 4th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

Zacks Equity Research

Genesis Healthcare (GEN) Reports Q2 Loss, Lags Revenue Estimates

Genesis Healthcare (GEN) delivered earnings and revenue surprises of 61.54% and -0.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

What's in Store for Genesis Healthcare (GEN) This Season?

Genesis Healthcare's (GEN) Q2 earnings should benefit from a stable census and reimbursement environment, effective cost management, improvement in therapy and staffing businesses.

Zacks Equity Research

Will Genesis Healthcare (GEN) Report Negative Earnings Next Week? What You Should Know

Genesis Healthcare (GEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Genesis Healthcare (GEN) Gains As Market Dips: What You Should Know

In the latest trading session, Genesis Healthcare (GEN) closed at $1.16, marking a +0.87% move from the previous day.

Zacks Equity Research

Zacks.com featured highlights include: Guess, Party City, Shoe Carnival, Genesis and Restoration Robotics

Zacks.com featured highlights include: Guess, Party City, Shoe Carnival, Genesis and Restoration Robotics

Zacks Equity Research

Is Genesis Healthcare (GEN) Stock Outpacing Its Medical Peers This Year?

Is (GEN) Outperforming Other Medical Stocks This Year?